News
-
-
-
PRESS RELEASE
Quantum BioPharma Previously Known as FSD Pharma (Nasdaq:HUGE) (CSE:HUGE) Invites Shareholders to Come Forward and Join Hands With the Company in the US700M$+ Court Case the Company Has Filed Against CIBC, RBC, and Others for Alleged Spoofing/Stock Price
Quantum BioPharma Ltd. seeks justice against alleged market manipulation, assembling legal teams to claim damages. Shareholders invited to join combined pursuit for justice against the Defendants -
-
-
PRESS RELEASE
Quantum Biopharma Announces that Sentinel Dosing has Started for the Phase-1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-Ms) in Australia
Quantum BioPharma starts sentinel dosing for Lucid-21-302 trial in multiple sclerosis treatment. Corporate update includes engaging ITG, Buyins, and Stockjock for Investor Relations Activities -
-
-
PRESS RELEASE
Quantum Biopharma (NASDAQ:QNTM) Posts Link on Its Website to Access the Filed Complaint Against CIBC World Markets, RBC Dominion Securities and Others, Seeking Damages in Excess of $700,000,000 USD, for Possible Stock Price Manipulation/Spoofing
Quantum BioPharma files $700M lawsuit against CIBC, RBC for market manipulation schemes. Press release details legal action and evidence. Law firms Christian Attar and Freedman Normand Friedland LLP to take the case on a contingency basis -
